Joan Swearer to Male
This is a "connection" page, showing publications Joan Swearer has written about Male.
Connection Strength
0.084
-
Swearer JM, Drachman DA, Li L, Kane KJ, Dessureau B, Tabloski P. Screening for dementia in "real world" settings: the cognitive assessment screening test: CAST. Clin Neuropsychol. 2002 May; 16(2):128-35.
Score: 0.011
-
Swearer JM, O'Donnell BF, Parker M, Kane KJ, Drachman DA. Psychological features in persons at risk for familial Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2001 May-Jun; 16(3):157-62.
Score: 0.010
-
Swearer JM, Kane KJ, Phillips CA, Weaver JP, Anderson TD, Lavoie MS. Predictive value of the intracarotid amobarbital test in bihemispheric seizure onset. Neurology. 1999 Jan 15; 52(2):409-11.
Score: 0.009
-
Swearer JM, O'Donnell BF, Kane KJ, Hoople NE, Lavoie M. Delayed recall in dementia: sensitivity and specificity in patients with higher than average general intellectual abilities. Neuropsychiatry Neuropsychol Behav Neurol. 1998 Oct; 11(4):200-6.
Score: 0.009
-
Swearer JM, O'Donnell BF, Ingram SM, Drachman DA. Rate of progression in familial Alzheimer's disease. J Geriatr Psychiatry Neurol. 1996 Jan; 9(1):22-5.
Score: 0.007
-
Burrows AM, Ravin PD, Novak P, Peters ML, Dessureau B, Swearer J, Pilitsis JG. Limbic and motor function comparison of deep brain stimulation of the zona incerta and subthalamic nucleus. Neurosurgery. 2012 Mar; 70(1 Suppl Operative):125-30; discussion 130-1.
Score: 0.006
-
Drachman DA, O'Donnell BF, Lew RA, Swearer JM. The prognosis in Alzheimer's disease. 'How far' rather than 'how fast' best predicts the course. Arch Neurol. 1990 Aug; 47(8):851-6.
Score: 0.005
-
Evans BA, Evans JE, Baker SP, Kane K, Swearer J, Hinerfeld D, Caselli R, Rogaeva E, St George-Hyslop P, Moonis M, Pollen DA. Long-term statin therapy and CSF cholesterol levels: implications for Alzheimer's disease. Dement Geriatr Cogn Disord. 2009; 27(6):519-24.
Score: 0.005
-
Swearer JM, Drachman DA, O'Donnell BF, Mitchell AL. Troublesome and disruptive behaviors in dementia. Relationships to diagnosis and disease severity. J Am Geriatr Soc. 1988 Sep; 36(9):784-90.
Score: 0.004
-
Hinerfeld DA, Moonis M, Swearer JM, Baker SP, Caselli RJ, Rogaeva E, St George-Hyslop P, Pollen DA. Statins differentially affect amyloid precursor protein metabolism in presymptomatic PS1 and non-PS1 subjects. Arch Neurol. 2007 Nov; 64(11):1672-3.
Score: 0.004
-
Klunk WE, Price JC, Mathis CA, Tsopelas ND, Lopresti BJ, Ziolko SK, Bi W, Hoge JA, Cohen AD, Ikonomovic MD, Saxton JA, Snitz BE, Pollen DA, Moonis M, Lippa CF, Swearer JM, Johnson KA, Rentz DM, Fischman AJ, Aizenstein HJ, DeKosky ST. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci. 2007 Jun 06; 27(23):6174-84.
Score: 0.004
-
Moonis M, Swearer JM, Dayaw MP, St George-Hyslop P, Rogaeva E, Kawarai T, Pollen DA. Familial Alzheimer disease: decreases in CSF Abeta42 levels precede cognitive decline. Neurology. 2005 Jul 26; 65(2):323-5.
Score: 0.003
-
Drachman DA, Swearer JM, Kane K, Osgood D, O'Toole C, Moonis M. The cognitive assessment screening test (CAST) for dementia. J Geriatr Psychiatry Neurol. 1996 Oct; 9(4):200-8.
Score: 0.002
-
O'Donnell BF, Swearer JM, Smith LT, Nestor PG, Shenton ME, McCarley RW. Selective deficits in visual perception and recognition in schizophrenia. Am J Psychiatry. 1996 May; 153(5):687-92.
Score: 0.002
-
Drachman DA, Swearer JM, O'Donnell BF, Mitchell AL, Maloon A. The Caretaker Obstreperous-Behavior Rating Assessment (COBRA) Scale. J Am Geriatr Soc. 1992 May; 40(5):463-70.
Score: 0.001
-
O'Donnell BF, Friedman S, Swearer JM, Drachman DA. Active and passive P3 latency and psychometric performance: influence of age and individual differences. Int J Psychophysiol. 1992 Mar; 12(2):187-95.
Score: 0.001